L Citrome

Summary

Affiliation: Nathan Kline Institute
Country: USA

Publications

  1. ncbi request reprint New antipsychotic medications: what advantages do they offer?
    L Citrome
    New York University, Orangeburg, USA
    Postgrad Med 101:207-10, 213-4. 1997
  2. ncbi request reprint Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns
    J Volavka
    New York University, Department of Psychiatry, Nathan Kline Institue for Psychiatric Research, Orangeburg 10962, USA
    Schizophr Res 35:S23-33. 1999
  3. doi request reprint Iloperidone redux: a dissection of the Drug Approval Package for this newly commercialised second-generation antipsychotic
    L Citrome
    Department of Psychiatry, New York University School of Medicine and the Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA
    Int J Clin Pract 64:707-18. 2010
  4. ncbi request reprint Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998
    L Citrome
    Clinical Research and Evaluation Facility, Nathan S Kline Institute for Psychiatric Research in Orangeburg, New York 10962, USA
    Psychiatr Serv 51:634-8. 2000
  5. doi request reprint How to search and harvest the medical literature: let the citations come to you, and how to proceed when they do
    L Citrome
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Int J Clin Pract 63:1565-70. 2009
  6. doi request reprint Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic
    L Citrome
    Department of Psychiatry, New York University School of Medicine, New York, NY, USA
    Int J Clin Pract 63:1762-84. 2009
  7. doi request reprint Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication
    L Citrome
    Department of Psychiatry, New York University School of Medicine, New York, NY, USA
    Int J Clin Pract 64:216-39. 2010
  8. ncbi request reprint Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
    L Citrome
    Department of Psychiatry, New York University School of Medicine, New York, NY, USA
    Int J Clin Pract 60:933-40. 2006
  9. ncbi request reprint Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia
    L Citrome
    Nathan Kline Institute for Psychiatric Research in Orangeburg, New York 10962, USA
    Psychiatr Serv 52:1510-4. 2001
  10. ncbi request reprint Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial
    J P Lindenmayer
    Psychopharmacology Research Unit, Manhattan Psychiatric Unit, Manhattan Psychiatric Center, Wards Island, New York 10035, USA
    J Clin Psychopharmacol 21:448-53. 2001

Detail Information

Publications22

  1. ncbi request reprint New antipsychotic medications: what advantages do they offer?
    L Citrome
    New York University, Orangeburg, USA
    Postgrad Med 101:207-10, 213-4. 1997
    ..Safety, efficacy, and cost will guide their use. None of these newer agents have been compared head-to-head with clozapine. More research is needed to place these new drugs into clinical perspective...
  2. ncbi request reprint Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns
    J Volavka
    New York University, Department of Psychiatry, Nathan Kline Institue for Psychiatric Research, Orangeburg 10962, USA
    Schizophr Res 35:S23-33. 1999
    ..g. randomization) used in typical designs of psychopharmacological clinical trials. Current research methods should be modified and new ones developed in order to progress in assessing the antiaggressive effects of treatments...
  3. doi request reprint Iloperidone redux: a dissection of the Drug Approval Package for this newly commercialised second-generation antipsychotic
    L Citrome
    Department of Psychiatry, New York University School of Medicine and the Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA
    Int J Clin Pract 64:707-18. 2010
    ..To describe the contents of a Drug Approval Package and to describe the efficacy and safety of iloperidone for the treatment of schizophrenia...
  4. ncbi request reprint Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998
    L Citrome
    Clinical Research and Evaluation Facility, Nathan S Kline Institute for Psychiatric Research in Orangeburg, New York 10962, USA
    Psychiatr Serv 51:634-8. 2000
    ..The study describes changes over time in the adjunctive use of valproate and other mood stabilizers-lithium, carbamazepine, and gabapentin--among hospitalized psychiatric patients with a diagnosis of schizophrenia...
  5. doi request reprint How to search and harvest the medical literature: let the citations come to you, and how to proceed when they do
    L Citrome
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Int J Clin Pract 63:1565-70. 2009
    ..There is a virtual avalanche of medical information available to clinicians and researchers. The traditional 'search' can be substantially augmented by proactive 'harvesting.'..
  6. doi request reprint Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic
    L Citrome
    Department of Psychiatry, New York University School of Medicine, New York, NY, USA
    Int J Clin Pract 63:1762-84. 2009
    ..To describe the efficacy and safety of asenapine for the treatment of schizophrenia and bipolar disorder...
  7. doi request reprint Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication
    L Citrome
    Department of Psychiatry, New York University School of Medicine, New York, NY, USA
    Int J Clin Pract 64:216-39. 2010
    ..To describe the efficacy, safety and cost of paliperidone palmitate, a depot antipsychotic medication recently approved for the treatment of schizophrenia...
  8. ncbi request reprint Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
    L Citrome
    Department of Psychiatry, New York University School of Medicine, New York, NY, USA
    Int J Clin Pract 60:933-40. 2006
    ..NNT and NNH can help place the wide array of CATIE results into clinical context, and permits quantification of the differences observed between the antipsychotics that were tested...
  9. ncbi request reprint Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia
    L Citrome
    Nathan Kline Institute for Psychiatric Research in Orangeburg, New York 10962, USA
    Psychiatr Serv 52:1510-4. 2001
    ..This study compared the specific antiaggressive effects of clozapine with those of olanzapine, risperidone, and haloperidol...
  10. ncbi request reprint Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial
    J P Lindenmayer
    Psychopharmacology Research Unit, Manhattan Psychiatric Unit, Manhattan Psychiatric Center, Wards Island, New York 10035, USA
    J Clin Psychopharmacol 21:448-53. 2001
    ..However, a trial with olanzapine can be recommended in these patients before moving to augmentation strategies, given the lack of proven alternatives and the observation that 16.7% of patients reached the response criteria...
  11. doi request reprint Olanzapine pamoate: a stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic
    L Citrome
    New York University School of Medicine, Department of Psychiatry, NY, USA
    Int J Clin Pract 63:140-50. 2009
    ..07% of injections, requiring patients to be observed for 3 h after injection. At present, there are no studies available that directly compare olanzapine pamoate with other antipsychotics other than oral olanzapine...
  12. ncbi request reprint Violent patients in the emergency setting
    L Citrome
    Department of Psychiatry, New York University, New York, USA
    Psychiatr Clin North Am 22:789-801. 1999
    ..The use of typical neuroleptics may lead to side effects, such as akathisia, which may in turn precipitate additional agitation. This may be obviated with the introduction of IM preparations of atypical antipsychotics...
  13. doi request reprint Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic
    L Citrome
    New York University School of Medicine, Department of Psychiatry, and Nathan S Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
    Int J Clin Pract 63:1237-48. 2009
    ..The aim of the study was to describe the efficacy and safety of iloperidone for the treatment of schizophrenia...
  14. ncbi request reprint Update on the biological treatment of aggression
    J Volavka
    Nathan S Kline Institute for Psychiatric Research, New York University, USA
    Actas Esp Psiquiatr 34:123-35. 2006
    ..The heterogeneity of aggressive behavior is a challenge for developing rational treatments. Emerging genetic findings hold a promise of future treatments of aggressive behavior developed on the basis of individual patients' genotypes...
  15. doi request reprint Compelling or irrelevant? Using number needed to treat can help decide
    L Citrome
    Department of Psychiatry, New York University School of Medicine, The Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Acta Psychiatr Scand 117:412-9. 2008
    ....
  16. doi request reprint Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia
    L Citrome
    New York University School of Medicine, Department of Psychiatry, Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA
    Int J Clin Pract 62:837-40. 2008
  17. doi request reprint Relative vs. absolute measures of benefit and risk: what's the difference?
    L Citrome
    Department of Psychiatry, New York University School of Medicine, New York and Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Acta Psychiatr Scand 121:94-102. 2010
    ..When appraising evidence clinicians are confronted with two types of comparisons: ratios, such as relative risk, and absolute differences, such as number needed to treat (NNT) or number needed to harm (NNH)...
  18. ncbi request reprint Paliperidone: quo vadis?
    L Citrome
    Department of Psychiatry, New York University School of Medicine, and the Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Int J Clin Pract 61:653-62. 2007
    ..With the impending availability of oral risperidone as a generic medication, cost of oral paliperidone will likely become a significant obstacle to its use...
  19. doi request reprint Heterogeneity of violence in schizophrenia and implications for long-term treatment
    J Volavka
    Department of Psychiatry, New York University School of Medicine, New York, NY, USA
    Int J Clin Pract 62:1237-45. 2008
    ..The aim of this review is to address the subtyping of violent behaviour in schizophrenia, and to relate the subtypes to treatment...
  20. ncbi request reprint Olanzapine: interpreting the label change
    L Citrome
    Int J Clin Pract 61:1960-2. 2007
  21. ncbi request reprint Testing for diabetes
    L Citrome
    Br J Psychiatry 186:78. 2005